Recent comments from the HKEX executives indicate they are seeing increasing demand for new issues with foreign money moving into the HK markets. Particular focus on biotech and other issues focused on the Chinese markets. This is a little counter-intuitive, but indicates that there is still strong belief in the Chinese domestic market opportunity, and that HK is still viewed as a more reliable and liquid IPO market than i might have expected.